Research output per year
Research output per year
Medicine
Universitetsparken 2
2100 København Ø
Research activity per year
Ole Jannik Bjerrum Born 1944.03.20 in Copenhagen, Denmark
1969 M.D. (cand. med.), University of Copenhagen
1978 Doctor of Medical Sciences (DMSc/dr.med.), University of Copenhagen
1988-98 Adjunct professor, Dept. Biochemistry & Nutrition, Technical University of DK
1999-2004 Adjunct professor, Faculty of Health, University of Southern Denmark
2001 Professor, Faculty of Pharmaceutical Sciences, University of Copenhagen
Appointments
1969-70 Internship at University Hospital of Copenhagen
1970-71 Research fellow at Institute of Biochemistry, University of Uppsala, Sweden
1971-74 Assistant professor, Protein Laboratory, University of Copenhagen
1974-87 Associate professor, Protein Laboratory, University of Copenhagen
1980-81 Visiting professor, Dept. of Biochemistry & Molecular Biology, Northwestern University, Ill, USA
1982-87 Director, Protein Laboratory, University of Copenhagen
1987-91 Director, Biolabs and Immunotechnology, Novo Nordisk A/S, Bagsvaerd.
1991-96 Principal Research Scientist, Assay and Cell Technology, Novo Nordisk A/S
1996-01 Research Counsellor, Corporate Research Affairs, Novo Nordisk A/S
2001- Professor of pharmacology, Faculty Pharmaceutical Sciences, University Copenhagen
2006 Visiting professor of pharmaceutical safety science, Faculty of PharmacyUniversity of Vienna
Publications and lectures,
1968- Author of 140 publications (94 are original papers in int. refereed journals)
1978 Dissertion.: Immunochemical analysis of membrane proteins
1983 Editor of "Electroimmunochemical Analysis of Membrane proteins", 481 pp, Elsevier
1988 Editor with N.H. Heegaard of "Handbook of Immunoblotting of Proteins", Vols. I, II 214, 265 pp CRC Press
1976- Invited lecturer at 38 international symposia and workshops
Areas of research expertise and supervision
At the Proteinlaboratory 1970-1987:
Membrane proteins: structure, enzymes, receptors and transporters. Clinical chemistry: plasmaproteins, antibodies, platelets, lymphocytes. Analytical techniques: electrophoresis, immunoblotting and diagnostics
Supervised 4 university candidate stipends , 1 ph.d and 11 master students
NovoNordisk 1987-2001
Monoclonal antibodies. Development and production of diagnostic ELISA kits for diabetes, pregnancy and myocardial infarction. High throughput screening receptor assays. Growth hormone secretagogues, Advanced glycation endproducts.
Co-supervised 6 ph.d.'s and 15 master students
Faculty of Pharmaceutical Sciences 2002-
Translational studies on the pathophysiology and treatment of neuropatic pain
Supervised 6 ph.d's and 31 master students
Contribution to Research Policy
Originator to the initiative New Safe Medicines Faster which impacted EU's 6th Framework programme (150 mio Euro) which paved the way for the public private EU joint Research programme: Innovative Medicines Initiative worth 1 bio Euro. The effort is based on more than 30 articles and reports.
Organization of Symposia and Congresses (major contributions)
1988 Co-organizer of 6th Int. Congress of Electrophoresis
1991 Organizer and chair of Scandinavian Electrophoresis Society's 3rd Congress
1996 Co-organizer of EC Meeting for Biotech Trainees: "Industrial Connections to Biotech"
1998 Co-organizer of EC First Conference of the Biotechnology & Finance Forum
2000 Co-organizer (chair) of EU/EUFEPS/EFPIA Workshop: New Safe Medicines Faster
2002 Organizer (chair) EUFEPS Conference: Biotech Medicines
2002 Organizer (chair) EU/EUFEPS Symposium: Afternoon Specials - New Safe Medicine Faster
2003 Co-organizer (chair) of EUFEPS/EUREKA Workshop: New Safe Medicines Faster
2004,07 Organizer EUFEPS Workshop: Safety Science
2004 Co-organizer EUFEPS Congress: New Safe Medicines. Towards Mechanistic Prediction
2005 Organizer EU/EUFEPS Workshop on Innovative Medicines
2006 Coorganizer of EUFEPS Conference on Pharmaceutical Safety Science, Austrian Science Academy
2006,07 Co-organizer EUFEPS/BioSim Conference Systems Biology.
Awards
2006 Danish Academy of Natural Sciences' Industry prize. Gold medal
2007 Pharmaceutical Sciences World Conferences Research Achievement Award
Offices & Memberships
1982-88 Member of the Board, Danish Biochemical Society (chairman 1984-86)
1983 Fellow, Danish Academy of Natural Sciences
1986-91 Council member, International Electrophoresis Society
1986-93 Member of the Board, Scandinavian Electrophoresis Society (chairman 1989-93)
1991 Fellow, Danish Academy of Technical Sciences
1992-98 Member of the Board, Danish Society Theoret. & Applied Medicine (chairman 1996-97)
1993-99 Appointed member, Danish Medical Research Council
1993-94 Member of the Board of Directors, PNA Diagnostics A/S
1994-97 Member, National Biotechnology Committee, Ministry of Research, DK
1994-98 Danish delegate: EU 4th Framework Programme Committee on Biotechnology, Brussels
1996-01 Member, Steering Committee for Center of Proteome Analysis, University Odense
1997-02 Chairman, Danish Association of Physicians in Private Employment
1997-98 Danish delegate, European Science and Technology Assembly (ESTA)
1998-01 Member of Committee on Industrial Relations, Eur. Fed. Pharm. Sciences (EUFEPS)
1999-03 Danish delegate: EU 5th Framework Programme Manag. Committee on Quality of Life
1999-02 Member Governing board, Eur. Assoc. for Promotion of Sci. & Tech. (Euroscience)
1999-07 Member of Executive Committee, President 2003-05, Eur.Fed.Pharm.Sciences, EUFEPS 2002-05 Member of Executive Committee of European Ethics Network (EEN)
2005-08 Danish delegate. EU Memberstate group, Technological Platform for Innovative Medicine IMI.
2008- Vicechairman EUFEPS Safety Sciences Network
2009 Member of European education team for IMI: SafeSciMET granted with 3 mio Euro
Better pharmacotherapies and profylaxes of neuropathic pain
Animal pain models for monitoring of pain releaving effect of new compounds
Development of in silico models for simulation of pharmacodynamic effects in pain treatment
Faster drug development through microdosing
Faster and improved registration of adverse drug reactions
Pharmacology and toxicology for pharmacy and pharmaceutical sciences students
Master of Industrial Drug Development
European Master of Safety Sciences of Medicines (Innovative Medicines Initiative and EU)
European research policy for the pharmaceutical industry and biotech
"New Safe Medicines Faster", Innovative Medicines Initiative
Research output: Contribution to journal › Journal article › Research › peer-review
Research output: Contribution to journal › Journal article › Research › peer-review
Research output: Contribution to journal › Journal article › Research › peer-review
Research output: Contribution to journal › Journal article › Research › peer-review
Research output: Contribution to journal › Journal article › Research › peer-review
Research output: Contribution to journal › Journal article › Research › peer-review
Research output: Contribution to conference › Poster › Research › peer-review
Research output: Contribution to journal › Review › Research › peer-review
Marie Louise (Marieke) De Bruin (Speaker), Christine Erikstrup Hallgreen (Speaker), Helle Christiansen (Organizer), Morten Andersen (Speaker), Ole Jannik Bjerrum (Organizer), Steffen Thirstrup (Speaker), Lourdes Cantarero Arevalo (Speaker), Jonathan Kimmelman (Invited speaker), Hans-Georg Eichler (Invited speaker), Hans Hoogland (Invited speaker), Jarno Hoekman (Invited speaker), Bastian Gauck (Invited speaker), Anders Perner (Invited speaker) & Carolyn Wilson (Invited speaker)
Activity: Participating in an event - types › Organisation of and participation in conference